US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:32:22 Source：Culture Capsule news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Who is Jacob Zuma, the former South African president disqualified from next week's election?
- Next：Saudi Arabia is going to sponsor the WTA women's tennis rankings under a new partnership
Related articles
- Analysis: Larson enters conversation with Verstappen as best drivers in the world
- Pictured: Plant
- Rooting for Trump to fail has made his stock shorters millions
- Jaguars select LSU WR Brian Thomas Jr. in the NFL draft, giving QB Trevor Lawrence a big target
- Kate Hudson hits the stage to debut songs from her new album Glorious at star
- Auto industry insiders highlight interdependence between China, Europe
- How a boy's offer of one dollar to a 'homeless man' sparked an incredible friendship
- Fallout v Halo: As Fallout 4 drops its next
- Yu Darvish extends scoreless innings streak to 25 in Padres' 9
- More than 50 aerospace information companies registered in Xiong'an New Area: official
- Verona confirms Serie A status for another year after beating Salernitana
- From flop to one
- Victoria Beckham does a 'U
- Debates to play a major role in Pennsylvania's 2024 US Senate election
- Socialite Jasmine Hartin enjoys beach snuggle with electrician hunk
- Art on the lips at hippiest cultural district in Hong Kong
- Fallout v Halo: As Fallout 4 drops its next
- How a boy's offer of one dollar to a 'homeless man' sparked an incredible friendship
- Hall of Fame outfielder Ken Griffey Jr. to lead Indianapolis 500 field in Corvette pace car
- Ten stocks to invest in NOW to profit from Rishi's defence spending boost
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Culture Capsule news portal sitemap